benznidazole 12.5 MG Oral Tablet

RxCUI: 1993222
RxNorm name: benznidazole 12.5 MG Oral Tablet
Display name: benznidazole 12.5 MG Oral Tablet
Full name: benznidazole 12.5 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Benznidazole	BENZNIDAZOLE	Exeltis USA, Inc.	8983d6a0-f63f-4f8e-bba4-38223f39e29b	2025-09-15	Warnings, Adverse reactions	Exact identifier rxcui: 1993222

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
8983d6a0-f63f-4f8e-bba4-38223f39e29b	benznidazole 12.5 MG Oral Tablet	PSN	13	These highlights do not include all the information needed to use BENZNIDAZOLE TABLETS safely and effectively. See full prescribing information for BENZNIDAZOLE TABLETS. BENZNIDAZOLE tablets, for oral use Initial U.S. Approval: 2017	20250915
8983d6a0-f63f-4f8e-bba4-38223f39e29b	benznidazole 12.5 MG Oral Tablet	SY	13	These highlights do not include all the information needed to use BENZNIDAZOLE TABLETS safely and effectively. See full prescribing information for BENZNIDAZOLE TABLETS. BENZNIDAZOLE tablets, for oral use Initial U.S. Approval: 2017	20250915
8983d6a0-f63f-4f8e-bba4-38223f39e29b	benznidazole 12.5 MG Oral Tablet	SCD	13	These highlights do not include all the information needed to use BENZNIDAZOLE TABLETS safely and effectively. See full prescribing information for BENZNIDAZOLE TABLETS. BENZNIDAZOLE tablets, for oral use Initial U.S. Approval: 2017	20250915